Breakdown | Dec 2024 | Dec 2024 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 14.00B | 13.30B | 11.89B | 11.55B | 11.91B |
Gross Profit | 14.00B | 13.13B | 11.89B | 11.55B | 11.91B |
EBITDA | 1.41B | 1.72B | 977.00M | 1.63B | 1.00B |
Net Income | 959.00M | 1.21B | 682.00M | 1.18B | 1.20B |
Balance Sheet | |||||
Total Assets | 66.49B | 64.71B | 60.93B | 48.55B | 54.15B |
Cash, Cash Equivalents and Short-Term Investments | 2.56B | 2.51B | 2.31B | 2.31B | 2.53B |
Total Debt | 2.97B | 3.03B | 2.78B | 2.78B | 2.78B |
Total Liabilities | 55.98B | 54.82B | 52.10B | 52.10B | 7.28B |
Stockholders Equity | 10.51B | 9.89B | 8.82B | -3.56B | 320.00M |
Cash Flow | |||||
Free Cash Flow | 2.48B | 2.19B | 2.45B | 2.45B | 1.97B |
Operating Cash Flow | 2.57B | 2.29B | 2.50B | 2.50B | 2.00B |
Investing Cash Flow | -1.32B | -1.84B | -1.51B | -1.51B | -1.23B |
Financing Cash Flow | -1.12B | -577.00M | -1.03B | -1.03B | -648.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $6.16B | 11.30 | 15.74% | 2.07% | 4.47% | 102.98% | |
74 Outperform | $6.06B | 18.88 | 19.49% | 3.94% | 10.29% | -4.70% | |
70 Outperform | $7.34B | 8.90 | 15.07% | 1.88% | 6.87% | 43.53% | |
70 Outperform | $4.74B | 12.76 | 12.19% | 1.91% | 12.27% | 66.53% | |
68 Neutral | $12.00B | 13.50 | 8.98% | 8.57% | 6.34% | -28.19% | |
67 Neutral | ¥752.53B | 11.08 | 7.55% | 3.21% | 7.70% | 14.15% | |
66 Neutral | $10.43B | 13.12 | 18.51% | 7.37% | 3.76% | -9.12% |
On July 3, 2025, CNA Financial entered into a General Release and Separation Agreement with Susan A. Stone, Executive Vice President and General Counsel, with her separation effective no later than July 31, 2025. The agreement includes a payment of $2,250,000 in installments and additional health and welfare benefits. In return, Ms. Stone agreed to non-interference and non-solicitation clauses for 12 months, and to cooperate with ongoing litigation and other matters.
The most recent analyst rating on (CNA) stock is a Sell with a $48.00 price target. To see the full list of analyst forecasts on CNA Financial stock, see the CNA Stock Forecast page.